An intensive one-day meeting on how CTCs and Liquid biopsies can impact biomarker research and precision medicine. With liquid biopsies receiving tremendous attention, our symposium will bring together leading companies to discuss how they can transform cancer diagnosis and become a standard tool in clinical oncology
The programme brings together international pharmaceutical organisations, leading biotech companies and globally renowned academic institutions specialising in CTCs & Liquid Biopsies
Full details on the Symposium including the presentations, topic areas and confirmed speakers will be released in the conference brochure in the coming weeks
Full Registration for Virtual Symposium: CTCs & Liquid Biopsies is not yet open. Please register your interest and a member of staff will be in touch to take your booking
Our LinkedIn group aims to foster discussion and collaboration between experts working in biomarker development and translational research.
Attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions working within CTCs & Liquid Biopsies.
Developing CTCs & Liquid Biopsies To Advance Precision Medicine
Improving Clinical Applications Of Liquid Biopsies
This event is part of the Biomarkers Series alongside our UK & USA events
The Symposium brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
The Institute of Cancer Research, London
University of Athens
Harvard Medical School
John Wayne Cancer Institute
Fraunhofer-Institute for Toxicology and Experimental Medicine
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of virtual, remote experiences.